Syndax Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SNDX and other ETFs, options, and stocks.

About SNDX

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES.

CEO

Michael A. Metzger

CEOMichael A. Metzger

Employees

270

Employees270

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2005

Founded2005

Employees

270

Employees270

SNDX Key Statistics

Market cap

792.50M

Market cap792.50M

Price-Earnings ratio

-2.39

Price-Earnings ratio-2.39

Dividend yield

—

Dividend yield—

Average volume

1.73M

Average volume1.73M

High today

$9.90

High today$9.90

Low today

$8.94

Low today$8.94

Open price

$9.30

Open price$9.30

Volume

2.88M

Volume2.88M

52 Week high

$25.07

52 Week high$25.07

52 Week low

$8.58

52 Week low$8.58

Analyst ratings

92%

of 12 ratings

Buy

91.7%

Hold

8.3%

Sell

People also own

Based on the portfolios of people who own SNDX. This list is generated using Robinhood data, and it’s not a recommendation.